It was among the largest scientific tests of the effects of flavonoids on type 2 diabetes executed to date. Based on the 2011 figures from the Centers for Disease Control, type 2 diabetes affects 8.3 % of the U.S. Population, or around 25.8 million people; FT reported that about 2 million Brits are influenced by the disease. In conducting their study, East Anglia researchers collected and analyzed blood samples and monitored meals consumption of 2,000 volunteer subjects. ‘An exciting getting’ We found that those who consumed a lot of anthocyanins and flavones [types of flavonoids] had lower insulin level of resistance, stated Professor Aedin Cassidy, the research leader.‘We are putting this information in the general public domain. We hope that lots of in academia and industry will use these data to find new drug targets, to judge current therapies, also to facilitate treatment for their patients with cancer.’ Related StoriesNew antenna-like device makes breast cancer surgery easier for surgeonsMeat-rich diet may increase kidney cancer riskOvarian cancer individuals with a brief history of oral contraceptive use have better outcomesThe genetic and molecular profiling data from the cell lines is usually freely available to the scientific community right here on the Broad Institute’s website. Investigators make use of cell lines to shed light on how brand-new or existing cancer medicines might best be used in patients. ‘Without access to a systematically collected group of molecular data, experts can’t match experiments from cell lines with individual tumors when new medicines become available,’ said William Sellers, Global Head of Oncology, NIBR.